Biomea Fusion, Inc. (BMEA) officer reports purchase of 30,000 shares
Rhea-AI Filing Summary
Biomea Fusion, Inc. executive and director Rainer M. Erdtmann reported buying 30,000 shares of Biomea Fusion common stock on 12/11/2025 at a weighted-average price of $1.4333 per share. After this transaction, he directly owns 723,027 shares.
Erdtmann also reports indirect holdings, including 19,400 shares held by a daughter, 20,000 shares held by a son, 20,000 shares held by another daughter, and additional shares held in two independent trusts and two Point Sur investment entities where he has voting or dispositive power but disclaims beneficial ownership beyond any pecuniary interest. He serves as President, Chief Operating Officer, Principal Financial Officer, Principal Accounting Officer, and a director of Biomea Fusion. The 30,000-share purchase was executed in multiple trades between $1.42 and $1.46 per share.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 30,000 | $1.4333 | $43K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.42 to $1.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. The shares are held by a trust having an independent trustee ("Trust 1"). The Reporting Person disclaims Section 16 beneficial ownership of the securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose. The shares are held by a trust having an independent trustee ("Trust 2"). The Reporting Person disclaims Section 16 beneficial ownership of the securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose. The shares are held directly by Point Sur Investors Fund I, LP ("Point Sur LP"). The General Partner of Point Sur LP is Point Sur Investors LLC. The Reporting Person is a managing member of Point Sur Investors, LLC and as such has voting and dispositive power over the securities held by Point Sur LP. The Reporting Person disclaims Section 16 beneficial ownership of the securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose. The shares are held directly by Point Sur Investors, LLC. The Reporting Person is a managing members of Point Sur Investors, LLC and as such has voting and dispositive power over the securities held by Point Sur Investors, LLC. The Reporting Person disclaims Section 16 beneficial ownership of the securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose.
FAQ
What insider transaction did Biomea Fusion, Inc. (BMEA) disclose in this Form 4?
The filing reports that Rainer M. Erdtmann purchased 30,000 shares of Biomea Fusion common stock on 12/11/2025 at a weighted-average price of $1.4333 per share.
Who is Rainer M. Erdtmann at Biomea Fusion, Inc. (BMEA)?
Rainer M. Erdtmann is a director of Biomea Fusion and serves as President, Chief Operating Officer, Principal Financial Officer, and Principal Accounting Officer, making him a key executive of the company.
How does the Form 4 describe the independent trusts and Point Sur investment entities?
The filing explains that Trust 1 and Trust 2 have independent trustees, and that certain shares are held directly by Point Sur Investors Fund I, LP and Point Sur Investors, LLC. Erdtmann has voting and dispositive power over these securities but disclaims Section 16 beneficial ownership except to the extent of his pecuniary interest, if any.
What does the weighted-average price disclosure in the Biomea Fusion (BMEA) Form 4 mean?
The Form 4 notes that the $1.4333 price is a weighted average because the 30,000 shares were bought in multiple transactions between $1.42 and $1.46. The filer undertakes to provide full trade-by-trade pricing details upon request.